Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s): QNTM

Healthcare

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.

CSE:QNTM - Post by User

Quantum BioPharma Ltd > FSD will offer new product alternatives

<< Previous

Bullboard Posts

Next >>

Post by Janemorris55on Sep 20, 2021 2:21pm

85 Views

Post# 33887274

FSD will offer new product alternatives

FSD Pharma to acquire 100% of the issued and outstanding shares Lucid Psycheceuticals in a deal valued at about $9 million in FSD stock. With this merger, FSD will offer new product alternatives to its customers, which makes it an attractive investment.

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale